BR0010249A - Processo para a preservação de vìrus e micoplasma - Google Patents

Processo para a preservação de vìrus e micoplasma

Info

Publication number
BR0010249A
BR0010249A BR0010249-0A BR0010249A BR0010249A BR 0010249 A BR0010249 A BR 0010249A BR 0010249 A BR0010249 A BR 0010249A BR 0010249 A BR0010249 A BR 0010249A
Authority
BR
Brazil
Prior art keywords
mycoplasma
virus
preservation
preserved
viruses
Prior art date
Application number
BR0010249-0A
Other languages
English (en)
Inventor
Eric Edward Worrall
Original Assignee
Eric Edward Worrall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909999.6A external-priority patent/GB9909999D0/en
Priority claimed from GBGB9926698.3A external-priority patent/GB9926698D0/en
Application filed by Eric Edward Worrall filed Critical Eric Edward Worrall
Publication of BR0010249A publication Critical patent/BR0010249A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18451—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Patente de Invenção: "PROCESSO PARA A PRESERVAçãO DE VìRUS E MICOPLASMA". Um material biologicamente ativo compreendendo um vírus vivo ou micoplasma é preservado através de um processo de dessecação, sem liofilização, em uma matriz de trealose vítrea tendo um teor de umidade residual não maior que 2%. O processo compreende dois estágios de secagem à vácuo. Em um tempo de ciclo muito menor que um processo de secagem de congelamento típico um vírus ou micoplasma pode ser preservado para prover um material que pode ser reidratado para render uma vacina tendo potência.
BR0010249-0A 1999-05-04 2000-05-03 Processo para a preservação de vìrus e micoplasma BR0010249A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9909999.6A GB9909999D0 (en) 1999-05-04 1999-05-04 Protection of sensitive viruses and bacteria in vaccines
GBGB9926698.3A GB9926698D0 (en) 1999-11-12 1999-11-12 Method for the preserving of viruses, bacteria and biomolecules
PCT/GB2000/001524 WO2000066710A2 (en) 1999-05-04 2000-05-03 Method for the preservation of viruses and mycoplasma

Publications (1)

Publication Number Publication Date
BR0010249A true BR0010249A (pt) 2002-02-13

Family

ID=26315490

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010249-0A BR0010249A (pt) 1999-05-04 2000-05-03 Processo para a preservação de vìrus e micoplasma

Country Status (18)

Country Link
US (1) US6664099B1 (pt)
EP (1) EP1175486B1 (pt)
JP (1) JP2002542815A (pt)
KR (1) KR100616195B1 (pt)
CN (1) CN1433465A (pt)
AP (1) AP1521A (pt)
AT (1) ATE366797T1 (pt)
AU (1) AU776982B2 (pt)
BR (1) BR0010249A (pt)
CA (1) CA2365277A1 (pt)
DE (1) DE60035497T2 (pt)
DK (1) DK1175486T3 (pt)
EA (1) EA004131B1 (pt)
ES (1) ES2290028T3 (pt)
MX (1) MXPA01011145A (pt)
OA (1) OA11936A (pt)
TR (1) TR200103149T2 (pt)
WO (1) WO2000066710A2 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569342B2 (en) 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
WO2005113147A2 (en) 2004-04-08 2005-12-01 Biomatrica, Inc. Integration of sample storage and sample management for life science
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
WO2007079147A2 (en) 2005-12-28 2007-07-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
EP2117354B1 (en) 2006-12-18 2018-08-08 Advanced BioNutrition Corp. A dry food product containing live probiotic
WO2009014774A1 (en) 2007-04-06 2009-01-29 Inviragen, Inc. Methods and compositions for live attenuated viruses
CA2694083A1 (en) 2007-07-26 2009-01-29 Sanofi Pasteur Limited Antigen-adjuvant compositions and methods
DE102007036695A1 (de) * 2007-08-03 2009-02-05 Ab Skf Getriebelageranordnung mit wenigstens einem zweireihigen Schrägkugellager
WO2010111565A2 (en) 2009-03-27 2010-09-30 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
EP2435554B1 (en) 2009-05-26 2017-07-26 Advanced Bionutrition Corporation Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
PL2529004T3 (pl) 2010-01-28 2017-12-29 Advanced Bionutrition Corporation Sucha szklista kompozycja zawierająca bioaktywny materiał
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
WO2012018639A2 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
EP2598660B1 (en) 2010-07-26 2017-03-15 Biomatrica, INC. Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
AR082682A1 (es) 2010-08-13 2012-12-26 Advanced Bionutrition Corp Composicion estabilizadora de almacenamiento en seco para materiales biologicos
ES2733211T3 (es) 2011-04-15 2019-11-28 Genelux Corp Cepas clonales de virus vaccinia atenuados y métodos de uso de las mismas
US20140140959A1 (en) 2012-10-05 2014-05-22 Aladar A. Szalay Energy Absorbing-Based Diagnostic and Therapeutic Methods Employing Nucleic Acid Molecules Encoding Chromophore-Producing Enzymes
US9725703B2 (en) 2012-12-20 2017-08-08 Biomatrica, Inc. Formulations and methods for stabilizing PCR reagents
US10238700B2 (en) 2014-01-02 2019-03-26 Genelux Corporation Oncolytic virus adjunct therapy with agents that increase virus infectivity
ES2786373T3 (es) 2014-06-10 2020-10-09 Biomatrica Inc Estabilización de trombocitos a temperaturas ambiente
MY194231A (en) 2015-07-29 2022-11-23 Advanced Bionutrition Corp Stable dry probiotic compositions for special dietary uses
US12558395B2 (en) 2015-07-29 2026-02-24 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
KR20250047404A (ko) 2015-12-08 2025-04-03 바이오매트리카 인코포레이티드 적혈구 침강 속도의 감소
CN105462840A (zh) * 2015-12-10 2016-04-06 浙江卫信生物药业有限公司 一种口腔支原体的活体冻干体的制备方法
IL318055A (en) 2022-07-08 2025-02-01 Viromissile Inc ONCOLYTIC VACCINIA VIRUSES AND RECOMBINANT VIRUSES AND METHODS OF USE THEREOF
CN116585724A (zh) * 2023-05-25 2023-08-15 广州和实生物技术有限公司 玻璃化真空干燥试剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
GB9125695D0 (en) * 1991-12-03 1992-01-29 Mastavac Limited Medical preparations
DE69628007T2 (de) * 1995-06-07 2003-11-27 Elan Drug Delivery Ltd., Ruddington Verfahren zur stabilen einarbeitung von substanzen in trockene geschäumte glasmatrizen und auf diese weise hergestellte zusammensetzungen
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation

Also Published As

Publication number Publication date
WO2000066710A2 (en) 2000-11-09
KR100616195B1 (ko) 2006-08-25
WO2000066710A3 (en) 2001-02-08
US6664099B1 (en) 2003-12-16
KR20020012201A (ko) 2002-02-15
CA2365277A1 (en) 2000-11-09
EA004131B1 (ru) 2003-12-25
JP2002542815A (ja) 2002-12-17
DK1175486T3 (da) 2007-10-29
DE60035497D1 (de) 2007-08-23
EP1175486A2 (en) 2002-01-30
OA11936A (en) 2006-04-12
MXPA01011145A (es) 2003-07-14
CN1433465A (zh) 2003-07-30
AU776982B2 (en) 2004-09-30
DE60035497T2 (de) 2007-10-31
ES2290028T3 (es) 2008-02-16
EP1175486B1 (en) 2007-07-11
AU4584400A (en) 2000-11-17
TR200103149T2 (tr) 2002-01-21
EA200101167A1 (ru) 2002-06-27
AP2001002335A0 (en) 2001-12-31
AP1521A (en) 2005-12-22
ATE366797T1 (de) 2007-08-15

Similar Documents

Publication Publication Date Title
BR0010249A (pt) Processo para a preservação de vìrus e micoplasma
BR0214822A (pt) Formulações contendo poxvìrus e processo para preparar composições contendo poxvìrus estáveis
NO20030411L (no) Farmasöytiske sammensetninger for behandlingen av smertefulle, inflammatoriske og ulceröse tilstander av fuktige epiteloverflater slik sommukositt, stomatitt og Behcets syndrom
AR020717A1 (es) Proteinas terapeuticamente activas en plantas.
DK0693281T3 (da) Farmaceutiske fluoxetinformuleringer
EP1385466A4 (en) ONCOLYTIC VIRUS THERAPY
BR0108402A (pt) Análogos de nucleosìdeo com base monocìclica carboxamidina modificado
DK1582204T3 (da) Echinocandin-farmaceutiske formuleringer, der indeholder miceldannende overfladeaktive stoffer
BR0111732A (pt) Prodrogas de 2-deóxi-beta-l-nucleosìdeos
ATE261308T1 (de) Dextran formulierungen zur behandlung entzündlicher gelenkerkrankungen
ATE276355T1 (de) Verfahren zur konservierung von biologisch aktivem material
BR9507846A (pt) Composição farmacéutica estável e fortemente concentrada de principio ativo da classe dos taxóides escolhido entre o docetaxol ou os derivados do docetaxol processo de preparação desta composição e utilização de uma solução congelada ou liofilizada
BR0111366A (pt) Vacina de poxvìrus recombinante do vìrus da sìndrome respiratória e reprodutiva de porcino (prrsv)
MD20020075A (en) Antimicrobial preparation with retarded release of the biologically active component, utilization thereof and process for implant obtaining
ES2185900T3 (es) Composicion farmacologica que comprende un componente p serico del amiloide para el tratamiento profilactico o terapeutico de infecciones viricas y un hit para la deteccion de union entre dicha composicion y componentes viricos.
TR200100450T2 (tr) Salvia türlerinden elde edilen ve virüslere karşı etkili olan bileşikler
BR0206995A (pt) Tratamento do vìrus da hepatite b
MX2023011087A (es) Composicion farmaceutica acuosa o composicion farmaceutica liofilizada estable.
DK0737072T3 (da) Anvendelse af simple og konjugerede dekstraner ved fremstilling af et medikament til at forhindre eller nedsætte risikoen f
UY28282A1 (es) Mediadores peptidicos del trasporte inverso de colesterol para el tratamiento de hipercolesterolemia
HUP0301506A3 (en) Pharmaceutical compositions for the treatment of painful, inflammatory and ulcerative conditions of moist epithelial surfaces such as mucositis, stomatitis and behcet's syndrome
BR9916893A (pt) Tratamento
MX9301922A (es) Composiciones para el tratamiento de infeccion y enfermedad ocasionadas por el virus de hepatitis b (hbv).
MX2025004270A (es) Formulacion de vacuna contra el dengue
ECSP003859A (es) Composicion para el tratamiento de tejidos dañados

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: ANHYDRO LIMITED (GB)

Free format text: TRANSFERIDO DE: ERIC EDWARD WORRALL

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13 E 24 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.